Epitope editing is being explored as a method to enable safe transplantation and in vivo cell selection. This approach may allow for less toxic stem cell transplants and potentially even chemotherapy-free bone marrow transplants. Research in this area appears to be progressing, with various studies investigating the use of epitope editing to modify stem cells and t cells for therapeutic purposes.